BAX:NYSE
Baxter International Inc
26,34 $
arrow_downward
-0,30%(-0,080) 1 d.
26,20 $
arrow_downward
-0,53% (-0,14)bedtimePēctirdzniecības
Slēgts: 11. nov., 16:00:02 GMT-5 · USD
search
Visi simboli
| Simbols | Cena | Izmaiņas | % izmaiņu |
|---|
insights_autoNotiek galveno ieskatu ģenerēšana par šādu tēmu: BAX…
Atvērt
26,11 $
Augsta
26,50 $
Zema
25,98 $
Tirgus kapitalizācija
13,63 mljrd.
Vid. apjoms
7,09 milj.
Apjoms
3,83 milj.
Dividende
0,15%
Ceturkšņa dividendes
0,01 $
Datums, kad tiek pārtraukta dividenžu izmaksa
2026. gada 28. aug.
Augstākā 52 ned.
30,00 $
Zemākā 52 ned.
15,73 $
Peļņa uz vienu akciju
-1,42 $
Beta
0,68
Apgrozībā esošās akcijas
517,35 milj.
Darbinieku skaits
38 tūkst.
Atvērt
26,11 $
Augsta
26,50 $
Zema
25,98 $
Tirgus kapitalizācija
13,63 mljrd.
Vid. apjoms
7,09 milj.
Apjoms
3,83 milj.
Dividende
0,15%
Ceturkšņa dividendes
0,01 $
Datums, kad tiek pārtraukta dividenžu izmaksa
2026. gada 28. aug.
Augstākā 52 ned.
30,00 $
Zemākā 52 ned.
15,73 $
Peļņa uz vienu akciju
-1,42 $
Beta
0,68
Apgrozībā esošās akcijas
517,35 milj.
Darbinieku skaits
38 tūkst.
Ziņas un raksti
No tīmekļa avotiem un ziņu partneriem
Eurasia Business News
·
pirms 5 stundām
Stock Market Today: Dow Jones, Nasdaq, S&P 500 Rally on November 11, 2026; Oil Rises, Gold Slips
ChartMill
·
pirms 3 stundām
S&P 500 After-Hours Movers: MNST, RDDT Among Gainers; VEEV, LLY Among Losers in Latest Session
marketscreener.com
·
pirms 5 stundām
S&P 500's Earnings Growth to Slow in 2027, 2028, UBS Says
Traders Union
·
pirms 2 stundām
Peter Tuchman: S&P 500 gains over $900 billion in market cap, closing up 1.3 percent
Profils
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.
The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion, across three business: "Medical Product and Therapies", "Healthcare Systems and Technologies" and Pharmaceuticals.
Baxter's Medical Product and Therapies business comprise two divisions: the first named "Advanced Surgery" that produce technologies to enhance surgeons' technique, increase efficiencies and improve outcomes. The second named "Infusion Therapies and Technologies" produces intravenous products and other products used in the delivery of fluids and drugs to patients.
Baxter's Healthcare System and Technologies business has four divisions "Front Line Care", "Digital Platform and Innovations", "Care and Connectivity Solutions" and "Global Services".
Baxter's Pharmaceuticals business produce inhalational anaesthetics and other differentiated hospital pharmaceuticals in areas of pain, critical care, anti-infection and oncology. Wikipedia
Par “Baxter International Inc”
ĢenerāldirektorsAndrew Hider
Darbinieki37,5 tūkst.
Dibināšanas datums1931
Galvenais birojsDeerfield, Ilinoisa, Amerikas Savienotās Valstis
SektorsHealth Care
Nozare-
Tīmekļa vietnebaxter.com